<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="49509">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02461693</url>
  </required_header>
  <id_info>
    <org_study_id>F150410009</org_study_id>
    <nct_id>NCT02461693</nct_id>
  </id_info>
  <brief_title>Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT</brief_title>
  <official_title>Evaluating the Role of Expectations in Response to Caffeine Consumption: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to examine the effect of expectancy on mood and alertness
      after consumption of caffeine &quot;treatment&quot; or placebo &quot;control&quot; pill, given that participants
      know their probability for receiving the caffeine versus placebo pill. Participants will be
      randomly assigned a probability (ranging from 0-100%) of receiving caffeine vs. placebo, and
      this probability will be revealed to them before consumption of the assigned pill and
      subsequent cognitive testing. At the time of consumption, neither study staff administering
      the intervention nor participants will know for certain which pill is given to each
      participant. Pill assignment will depend on pre-determined randomization probabilities,
      which will be provided and assigned by the study statistician. By revealing participants'
      individual probability of receiving the caffeine pill, we will induce positive or negative
      expectancies regarding likelihood for receipt of the caffeine pill. These experimental
      manipulations will: 1) estimate the effect of expectancy on cognitive and affective
      outcomes, and 2) allow for a more direct estimate of the effect of the caffeine pill under
      real-world conditions than would a conventional randomized trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mood state Score on POMS-2 test</measure>
    <time_frame>30 minutes post pill consumption</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Vigilance Score on computer-based test using random, visual stimulus</measure>
    <time_frame>45 to 105 minutes post pill consumption</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">205</enrollment>
  <condition>Caffeine</condition>
  <condition>Affect</condition>
  <condition>Other Stimulant Use, Unspecified</condition>
  <condition>Cognitive Ability, General</condition>
  <arm_group>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One-time treatment with 200mg caffeine pill</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One-time treatment with lactose-based placebo pill</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>200mg delivered as pill; one-time dose</description>
    <arm_group_label>Caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19 years-old or older

          -  available to participate on the dates specified

          -  willing to take a caffeine or placebo pill at study session

          -  currently enrolled at UAB

        Exclusion Criteria:

          -  self-reported use of ADHD medication

          -  self-reported use of anxiety medication

          -  self-reported use of sleep medication

          -  self-reported use of nicotine products

          -  self-reported lactose intolerance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David B Allison, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 23, 2015</lastchanged_date>
  <firstreceived_date>June 1, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>David Allison, Phd</investigator_full_name>
    <investigator_title>Associate Dean for Science, School of Public Health</investigator_title>
  </responsible_party>
  <keyword>Vigilance</keyword>
  <keyword>Mood</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Probability</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
